Turn off MathJax
Article Contents
Zaihui ZHANG, YuanYuan LÜ, Zhihong WANG. Genetic Variant Analysis in 10 Patients with Polycystic Kidney Disease[J]. Journal of Kunming Medical University.
Citation: Zaihui ZHANG, YuanYuan LÜ, Zhihong WANG. Genetic Variant Analysis in 10 Patients with Polycystic Kidney Disease[J]. Journal of Kunming Medical University.

Genetic Variant Analysis in 10 Patients with Polycystic Kidney Disease

  • Received Date: 2025-12-31
    Available Online: 2026-06-11
  •   Objective  To identify the pathogenic gene variants in ten polycystic kidney disease (PKD)pedigrees, to clarify the molecular diagnosis of the probands and other family members.  Methods  Clinical data of 10 PKD pedigrees was collected, genomic DNA was extracted from peripheral blood samples of the probands and family members, and sequenced by next generation sequencing (NGS), candidate variants wereanalyzed by bioinformatics and confirmed by Sanger sequencing.  Results  A total of 8 PKD1 variants and 3 PKD2 variants and 2 PKHD1 variants were found in the 10 pedigrees. Among these, PKD1: c.3416_3417delTG, c.10264_10265insTCGG, c.10762T>C and PKD2: c.602delG, c.1548G>C variants have not been reported in HGMD database, ClinVar database or previous literature.According to the American College of Medical Genetics and Genomics (ACMG) standards and guidelines for the interpretation of sequence variants, PKD1: c.3416_3417delTG, c.10264_10265insTCGG and PKD2: c.602delG were classified as likely pathogenic (LP), PKD1: c.10762T>C and PKD2: c.1548 G>C were classified as variantsof uncertain significance (VUS).   Conclusion  In this study, the cause of PKD in 10 pedigrees was identified by molecular diagnosis, and three novel PKD1gene variants and two novel PKD2 gene variants were reported for the first time, which expanded the mutation spectrum of PKD.
  • loading
  • [1]
    Bergmann C, Guay-Woodford L M, Harris P C, et al. Polycystic kidney disease[J]. Nat Rev Dis Primers, 2018, 4(1): 50. doi: 10.1038/s41572-018-0047-y
    [2]
    Boletta A, Caplan M J. Physiologic mechanisms underlying polycystic kidney disease[J]. Physiol Rev, 2025, 105(3): 1553-1607. doi: 10.1152/physrev.00018.2024
    [3]
    Aung T T, Bhandari S K, Chen Q, et al. Autosomal dominant polycystic kidney disease prevalence among a racially diverse United States population, 2002 through 2018[J]. Kidney360, 2021, 2(12): 2010-2015. doi: 10.34067/KID.0004522021
    [4]
    Gordon C E, Garimella P S, Perrone R D, et al. Autosomal dominant polycystic kidney disease: Core curriculum 2025[J]. Am J Kidney Dis, 2025, 86(4): 525-542.
    [5]
    Chebib F T, Hanna C, Harris P C, et al. Autosomal dominant polycystic kidney disease: A review[J]. Jama, 2025, 333(19): 1708-1719. doi: 10.1001/jama.2025.0310
    [6]
    Chang A R, Moore B S, Luo J Z, et al. Exome sequencing of a clinical population for autosomal dominant polycystic kidney disease[J]. Jama, 2022, 328(24): 2412-2421. doi: 10.1001/jama.2022.22847
    [7]
    Guay-Woodford L M. Autosomal recessive polycystic kidney disease: update on pathogenesis and emerging therapies[J]. Curr Opin Nephrol Hypertens, 2025, 34(2): 89-96.
    [8]
    Goggolidou P, Richards T. The genetics of Autosomal Recessive Polycystic Kidney Disease (ARPKD)[J]. Biochim Biophys Acta Mol Basis Dis, 2022, 1868(4): 166348.
    [9]
    Jdiaa S S, Mustafa R A, Yu A S L. Treatment of autosomal-dominant polycystic kidney disease[J]. Am J Kidney Dis, 2025, 85(4): 491-500. doi: 10.1053/j.ajkd.2024.08.008
    [10]
    Stenson P D, Mort M, Ball E V, et al. Human Gene Mutation Database (HGMD)[DB/OL]. Cardiff: Institute of Medical Genetics, Cardiff University, (2020)[2026-04-27]. https://www.hgmd.cf.ac.uk. HGMD®
    [11]
    Landrum M J, Benson M, Brown G R, et al. ClinVar[DB/OL]. Bethesda: National Center for Biotechnology Information (NCBI), (2025)[2026-04-27]. https://www.ncbi.nlm.nih.gov/clinvar/.
    [12]
    Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. doi: 10.3410/f.725378375.793543190
    [13]
    Borghol A H, Bou Antoun M T, Hanna C, et al. Autosomal dominant polycystic kidney disease: An overview of recent genetic and clinical advances[J]. Ren Fail, 2025, 47(1): 2492374. doi: 10.1080/0886022X.2025.2492374
    [14]
    Cadnapaphornchai M A, Dell K M, Winyard P J D. Polycystic kidney disease in children: the current status and the next horizon[J]. Adv Clin Exp Med, 2025, 86(3): 383-392.
    [15]
    Alshriem L A, Buqaileh R, Alorjani Q, et al. Ciliary ion channels in polycystic kidney disease[J]. Cells, 2025, 14(6): 459. doi: 10.3390/cells14060459
    [16]
    Burgmaier K, Brinker L, Erger F, et al. Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants[J]. Kidney Int, 2021, 100(3): 650-659. doi: 10.1016/j.kint.2021.04.019
    [17]
    Petit C, Cantarovich D, Langs V, et al. Genetic screening is essential in polycystic kidney disease: It is never too late![J]. Nephrol Ther, 2022, 18(2): 144-147.
    [18]
    Authors N. KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)[J]. Kidneys, 2025, 14(1): 7-16. doi: 10.22141/2307-1257.14.1.2025.494
    [19]
    Hwang Y H, Conklin J, Chan W, et al. Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease[J]. J Am Soc Nephrol, 2016, 27(6): 1861-1868. doi: 10.1681/ASN.2015060648
    [20]
    Carrera P, Calzavara S, Magistroni R, et al. Deciphering variability of PKD1 and PKD2 in an Italian cohort of 643 patients with autosomal dominant polycystic kidney disease (ADPKD)[J]. Sci Rep, 2016, 6: 30850. doi: 10.1038/srep30850
    [21]
    Chang M Y, Chen H M, Jenq C C, et al. Novel PKD1 and PKD2 mutations in Taiwanese patients with autosomal dominant polycystic kidney disease[J]. J Hum Genet, 2013, 58(11): 720-727. doi: 10.1038/jhg.2013.91
  • Relative Articles

    [1] Chuanqi YANG, Ruolian ZHAO, Yajuan TANG, Zijie LIU, Huan LI, Hui ZHANG, Lin CHAI. Core Active Substances and Molecular Mechanisms of Traditional Chinese Medicine in Treating IgA Nephropathy Based on Data Mining and Network Pharmacology. Journal of Kunming Medical University,
    [2] Le ZHANG, Jiawei XIA, Depan CHEN, Haiwen LI, Bin BAI, Yatao YANG, Xiang LI, Kaiyi ZHANG. Value of Next-generation Sequencing Combined with GeneXpert MTB/RIF in Early Diagnosis of Tuberculous Meningitis. Journal of Kunming Medical University,
    [3] Menghuan LI, Li AI, Yongxia LI. Single-cell RNA Sequencing: A New Perspective in the Study of Chronic Obstructive Pulmonary Disease. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20250301
    [4] Yanhong SUN, Yaoyao CHEN, Jienan ZHOU, Meiling ZHANG, Zhaosheng LIU, Xiaonan ZHAO. Molecular Epidemiological Investigation of the Fourth Human Case of Eurasian Avian-like H1N1 Swine Influenza Virus Infection in Yunnan Province. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20250404
    [5] Lizhu ZHAO, Ying DONG, Yue DENG, Lihua YANG. Correlation between Epithelial Cell Related Genes and Prognosis of Patients with Ovarian Cancer based on Single Cell Sequencing. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20240402
    [6] Xi LIU, Xin LIU, Jingjing CAI, Yaxi DU, Hongsheng LI, Yongchun ZHOU. Application of Nanopore Sequencing in Tumor with Infection. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230710
    [7] Tong XU, Yantuanjin MA, Yuhang ZHANG, Qiuyue HE, Wei HUANG, Mengxin LU, Jian TANG, Jianping HE, Guoqing JIANG, Yuan QIAN. Second-generation Sequencing Study of Trophoblast Cells in vitro Stimulated by Different Concentrations of Vitamin D. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20221021
    [8] Li Xiu Ling , Dong Xu Dong , Yan Fang , Chen Chun Hou , Qing Sha , Liu Huan Ling . . Journal of Kunming Medical University,
    [9] Pu Dong , Li Xiao Fei , Yu Ting Ting , Wang Hong Ying , Zhang Run Wu , Li Li Hua , Bai Jing , Ding Cai Mei , Li Dong Ling , Yang Yong Rui . . Journal of Kunming Medical University,
    [10] Yin Shun Hui , Zhan Ye Ming , Jia Feng Mei , Ran Li Quan , Zhang Ming Zhu . . Journal of Kunming Medical University,
    [11] Tu Yun Gui , Du Qiong , Yu Ying Hui , Lv Jing Liang , Chen Tian Yan , Zhang You Wang , Li Jie , Chen Rui Xia , Song Yu . . Journal of Kunming Medical University,
    [12] Pu Dong , Yu Ting Ting , Wang Hong Ying , Li Li Hua , Zhang Run Wu , Ding Cai Mei , Bai Jing , Li Dong Ling , Li Xiao Fei . . Journal of Kunming Medical University,
    [13] Zhao Fei , Jiang Yan Ling , Zhang Shou Xun , Xia Sheng , Bao Jian Jun , Zhang Nin , Yang Xiao Pei , Zhong Shu Rong . Pyrosequencing Detection Pass Ratio for DNA Methylation. Journal of Kunming Medical University,
    [14] Liu Yu . The Value of Renal Tubular Injury Biomarkers in Diagnosis of Primary Nephrotic Syndrome. Journal of Kunming Medical University,
    [15] Zhou Ying . Clinical Application of the Next-generation Sequencing Technology. Journal of Kunming Medical University,
    [16] Du Xing Hua . . Journal of Kunming Medical University,
    [17] Lu Fang Li . . Journal of Kunming Medical University,
    [18] Zhong Hua . . Journal of Kunming Medical University,
    [19] Liao Jia Xian . . Journal of Kunming Medical University,
    [20] Tan Lu . . Journal of Kunming Medical University,
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(3)

    Article Metrics

    Article views (60) PDF downloads(26) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return